Apcalis SX Oral Jelly: Fast-Acting Erectile Dysfunction Relief
Apcalis SX Oral Jelly
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per sachet | Price | Buy |
| 10 | $4.80 | $48.00 (0%) | 🛒 Add to cart |
| 20 | $4.30 | $96.00 $86.00 (10%) | 🛒 Add to cart |
| 30 | $3.90 | $144.00 $117.00 (19%) | 🛒 Add to cart |
| 50 | $3.62 | $240.00 $181.00 (25%) | 🛒 Add to cart |
| 70 | $3.33 | $336.00 $233.00 (31%) | 🛒 Add to cart |
| 100 | $3.25
Best per sachet | $480.00 $325.00 (32%) | 🛒 Add to cart |
Apcalis SX Oral Jelly is a specialized phosphodiesterase type 5 (PDE5) inhibitor formulated for the treatment of erectile dysfunction. It contains Tadalafil as its active pharmaceutical ingredient, delivered in a convenient, palatable oral jelly format for rapid absorption and predictable pharmacokinetics. This formulation is designed to offer a reliable therapeutic option with an onset of action typically within 15–30 minutes, supporting spontaneity and reducing planning-related anxiety. It is intended for adult male use under appropriate medical supervision.
Features
- Active ingredient: Tadalafil 20mg per sachet
- Pharmaceutical form: Oral jelly (fruit-flavored)
- Rapid disintegration and absorption profile
- Pre-measured single-dose sachets for accurate dosing
- No requirement for water intake during administration
- Manufactured under GMP conditions
Benefits
- Facilitates rapid onset of erectile response, typically within 15–30 minutes
- Supports spontaneity and reduces anticipatory anxiety associated with timed dosing
- Offers prolonged therapeutic window of up to 36 hours
- Easy-to-administer format ideal for individuals with swallowing difficulties
- Predictable pharmacokinetics with low intra-subject variability
- Discreet and portable single-use packaging
Common use
Apcalis SX Oral Jelly is indicated for the management of erectile dysfunction (ED) in adult males. It is used to improve erectile function by enhancing blood flow to the corporal tissues during sexual stimulation. Clinical use demonstrates efficacy across various ED etiologies, including vasculogenic, neurogenic, and psychogenic origins. It is not indicated for use in women, adolescents, or pediatric populations.
Dosage and direction
The recommended dose is one 20mg sachet taken orally approximately 15–30 minutes prior to anticipated sexual activity. The jelly should be squeezed directly into the mouth and swallowed; no water is required. Do not exceed one dose per 24-hour period. Dosage adjustment may be necessary in patients with renal or hepatic impairment, or in those taking concomitant CYP3A4 inhibitors. Healthcare providers should individualize therapy based on efficacy and tolerability.
Precautions
- Cardiovascular status should be assessed prior to initiation, as sexual activity carries potential cardiac risk
- Use with caution in patients with anatomical penile deformities or conditions predisposing to priapism
- Avoid use in patients with severe hepatic impairment (Child-Pugh Class C)
- Not recommended for use with other PDE5 inhibitors or erectile dysfunction treatments
- May cause hypotension; caution advised in patients on antihypertensive therapy
- Patients should seek immediate medical attention for erections lasting more than 4 hours
Contraindications
- Concomitant use with organic nitrates or nitric oxide donors in any form
- History of hypersensitivity to Tadalafil or any excipients in the formulation
- Patients with severe cardiovascular instability, recent myocardial infarction, or unstable angina
- Hereditary degenerative retinal disorders, including retinitis pigmentosa
- Concomitant use with potent CYP3A4 inhibitors in patients with compromised hepatic or renal function
Possible side effects
Common adverse reactions (≥2%) include:
- Headache
- Dyspepsia
- Back pain
- Myalgia
- Nasal congestion
- Flushing
- Dizziness
Less frequent side effects may include:
- Visual disturbances (blurred vision, cyanopsia)
- Hearing loss or tinnitus
- Priapism (prolonged erection)
- Hypotension
- Gastroesophageal reflux
Drug interaction
- Contraindicated with nitrates due to risk of severe hypotension
- Potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase Tadalafil exposure
- Alpha-adrenergic blockers may potentiate hypotensive effects
- Moderate interaction with CYP3A4 inducers (e.g., rifampin) may reduce efficacy
- Grapefruit juice may increase plasma concentrations and should be avoided
Missed dose
As Apcalis SX Oral Jelly is taken on an as-needed basis, there is no scheduled dosing regimen. No make-up dose is required if a dose is missed. Do not take extra doses to compensate for missed administrations.
Overdose
In cases of suspected overdose, standard supportive measures should be implemented. Expected effects would be consistent with Tadalafil’s vasodilatory properties, including potentially severe hypotension. Cardiovascular monitoring and appropriate management of hypotension (e.g., Trendelenburg positioning, IV fluids) are recommended. Dialysis is unlikely to be effective due to high protein binding.
Storage
Store at room temperature (15–30°C) in original packaging. Protect from moisture and direct sunlight. Keep out of reach of children and pets. Do not use after expiration date printed on sachet.
Disclaimer
This product requires a prescription and should be used only under medical supervision. This information is for educational purposes and does not replace professional medical advice. Patients should consult their healthcare provider for diagnosis and appropriate treatment options. Not all users will experience the same results.
Reviews
Clinical studies demonstrate that 81% of men taking Tadalafil 20mg reported improved erections versus 35% on placebo. Patient satisfaction surveys indicate high acceptability of the oral jelly formulation, particularly among those who prefer alternatives to tablets. Real-world evidence supports maintained efficacy with long-term use when prescribed appropriately.